Emerging entrepreneurs from the University of Toronto and its affiliated hospitals are translating bold scientific ideas into real-world biotech solutions
Financing will support the company’s advancement of its 'dual binding' disease therapy
Pitches focused on treating a difficult form of cancer and enhancing gene therapy treatments take the top spots
$25K and $10K will be awarded to the top regenerative or precision medicine innovations
Myoxa Therapeutics and Specifix Dx win the Building a Biotech Venture Pitch Competition
Teams are working on a range of innovations including discovering new drug compounds, engineering cell therapies, preventing neurodegeneration and revolutionizing eye treatments
Research grants awarded to products that could impact cancer and rare genetic diseases.
Trainee-led teams will pitch their ideas in front of expert judges for the chance to receive one of two research funding grants.
Thanks to this team’s effective storytelling, sound science and clear pathway to translation, HDAX was chosen by the judges to receive research funding.
Teams were selected because of the strength of their concepts, which all have potential to make a positive contribution to the regenerative medicine-related ecosystem.
New partnership with Health Innovation Hub offers a focused workshop, expert mentoring, and pitch competition with up to $25,000 in funding on offer to further develop product or venture
